Abiopharma

General Announcement: INTENTION TO DEAL DURING CLOSED PERIOD

MANCHESTER KEITH S 🔴 sold 1.2M shares of Roivant Sciences Ltd. (ROIV) at $26.76 ($32.7M) Transaction Date: Feb 11, 2026 | Filing ID: 052130

Gold Daniel Allen 🔴 sold 1.2M shares of Roivant Sciences Ltd. (ROIV) at $26.76 ($32.7M) Transaction Date: Feb 11, 2026 | Filing ID: 052128

📋 Leone D Patterson (Ex-officer) plans to sell 129K shares of Zymeworks Inc. (at $23.17 each, total $3.0M) Filed: Feb 13, 2026 | ID: 052127

QVT Financial LP 🔴 sold 1.2M shares of Roivant Sciences Ltd. (ROIV) at $26.76 ($32.7M) Transaction Date: Feb 11, 2026 | Filing ID: 052106

Jones Mitchell Lawrence 🟡 adjusted position in 2.0K shares (1 derivative) of PALISADE BIO, INC. (PALI) at $1.75 Transaction Date: Feb 11, 2026 | Filing ID: 006833

Director Finley John David 🟡 adjusted position in 3.9K shares (1 derivative) of PALISADE BIO, INC. (PALI) at $1.75 Transaction Date: Feb 11, 2026 | Filing ID: 006831

Dahms Bradford D. 🟢 acquired 264.7K shares (1 derivative) of Jade Biosciences, Inc. (JBIO) at $14.81 ($3.4M) Transaction Date: Feb 12, 2026 | Filing ID: 052056

Balta Elizabeth 🟢 acquired 196.9K shares (1 derivative) of Jade Biosciences, Inc. (JBIO) at $14.81 ($2.5M) Transaction Date: Feb 12, 2026 | Filing ID: 052055

Frohlich Tom 🟢 acquired 551.2K shares (1 derivative) of Jade Biosciences, Inc. (JBIO) at $14.81 ($7.0M) Transaction Date: Feb 12, 2026 | Filing ID: 052054